Synergy CHC Corp. (SNYR) - Dilution Analysis

S-1 filing: This prospectus relates to the resale of up to 101,710,000 shares of common stock by Hudson Global Ventures, LLC, which includes shares from an equity line of credit, warrant exercises, and consulting agreements.

10-Q filing | 14.9M shares outstanding

S-3 filing: Synergy CHC Corp. files an S-3 form to offer various securities, including common stock, preferred stock, debt securities, subscription rights, and units, with an aggregate offering price not exceeding $100 million.

10-Q filing | 11.3M shares outstanding

8-K filing: Synergy CHC Corp. sold 1,750,000 shares of common stock at $2.50 per share on August 27, 2025, raising gross proceeds of $4.375 million before expenses. ($4.38M proceeds)

S-1 filing: Synergy CHC Corp is offering up to 1,275,510 shares of its common stock at an assumed public offering price of $3.92 per share, with an underwriter option for an additional 191,326 shares.

10-Q filing | 8.9M shares outstanding

8-K filing: Synergy CHC Corp. issued a pre-funded common stock purchase warrant to Knight Therapeutics International S.A. to purchase up to 428,570 shares of common stock in connection with an equity conversion of debt.

10-Q filing | 8.6M shares outstanding

10-K filing | 8.8M shares outstanding

10-Q filing | 8.7M shares outstanding

S-1/A filing: Synergy CHC Corp. is offering 1,000,000 shares of its common stock at an estimated price between $9.00 and $11.00 per share, with Roth Capital Partners as the underwriter.

S-1/A filing: Synergy CHC Corp. is offering 1,000,000 shares of its common stock in an initial public offering, with an expected price between $9.00 and $11.00 per share, and has granted underwriters an option to purchase up to 150,000 additional shares to cover over-allotments.

S-1/A filing: Synergy CHC Corp. is offering 2,000,000 shares of its common stock with an estimated IPO price between $9.00 and $11.00 per share.

S-1/A filing: Synergy CHC Corp. is offering 2,000,000 shares of common stock with an estimated IPO price between $9.00 and $11.00, and has granted a 30-day over-allotment option to purchase up to 300,000 additional shares.

S-1/A filing: Synergy CHC Corp. is offering shares of common stock in an initial public offering, with a 30-day option for underwriters to purchase additional shares to cover over-allotments.

S-1/A filing: Synergy CHC Corp. is filing an S-1/A to offer shares of its common stock.

S-1/A filing: Synergy CHC Corp. is offering shares of its common stock in an initial public offering, with a proposed listing on the Nasdaq Capital Market under the symbol SNYR.

S-1 filing: Synergy CHC Corp. is offering shares of its common stock in an initial public offering, with the intention to list on the Nasdaq Capital Market under the symbol 'SNYR'.

RW filing: The company has withdrawn its planned registered offering of common stock, as the registration statement has not been declared effective and no securities were sold.

S-1/A filing: Synergy CHC Corp. is filing an S-1/A form for a common stock offering, with B. Riley Securities as the underwriter, to raise capital for repaying debt, supporting organic growth, advertising, and potential acquisitions.

S-1/A filing: Synergy CHC Corp. is offering shares of its common stock in an initial public offering, with B. Riley Securities as the underwriter. The company has granted a 30-day over-allotment option to the underwriters.

S-1/A filing: This S-1/A filing from Synergy CHC Corp. relates to a proposed offering of common stock, with B. Riley Securities as the underwriter, and includes an over-allotment option; the company intends to list its common stock on the Nasdaq Capital Market under the symbol SNYR.

S-1 filing: Synergy CHC Corp. is filing an S-1 form for an initial public offering of its common stock.

10-Q filing | 89.9M shares outstanding

10-K filing | 89.9M shares outstanding